|

Zasocitinib Clinical Trials

3 actively recruiting trials across 3 locations

Also known as: NDI-034858, TAK- 279

Pipeline

Phase 3: 3

Top Sponsors

  • Takeda3

Indications

  • Psoriatic Arthritis3
  • Arthritis3

Chandler, Arizona1 trial

A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines

AARR- Chandler AZ

Phase 3

Mesa, Arizona1 trial

A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines

Arizona Arthritis & Rheumatology Research, PLLC | Phoenix, AZ

Phase 3

Fountain Valley, California1 trial

Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis

First OC Dermatology Research Inc.

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.